»ù±¾ÊÍÒå:

Ö¯Âö¹­×ÛºÏÕ÷

ÍøÂçÊÍÒå

1)aortic arch syndrome,Ö¯Âö¹­×ÛºÏÕ÷

2)pulseless disease,Ö÷¶¯Âö¹­×ÛºÏÕ÷

3)Branchial arch syndrome,Èú¹­×ÛºÏÕ÷

4)first arch syndrome,µÚÒ»Èú¹­×ÛºÏÕ÷

5)Coronary syndrome,¹ÚÂö×ÛºÏÕ÷

6)superior mesenteric artery syndromeª¤,¶¯Âö×ÛºÏÕ÷

Ó÷¨ºÍÀý¾ä

Therapeutic efficacy and safety of intra-aortic balloon pump in elderly patients with acute coronary syndrome during the percutaneous coronary intervention;

Ö÷¶¯ÂöÄÚÇòÄÒ·´²«¸¨ÖúÀÏÄê¼±ÐÔ¹ÚÂö×ÛºÏÕ÷»¼Õß½éÈëÖÎÁÆÁÙ´²ÁÆЧ·ÖÎö

Objective: To evaluate the anxiety level of patients with coronary syndrome.

Ä¿µÄ:ÕýÈ·ÆÀ¹À¹ÚÂö×ÛºÏÕ÷»¼ÕߵĽ¹ÂÇˮƽ¡£

The Clinical Study of the Relation between Metabolic Syndrome Complicated by Acute Coronary Syndrome and Coronary Artery Lesions;

´úл×ÛºÏÕ÷²¢¼±ÐÔ¹ÚÂö×ÛºÏÕ÷Óë¹Ú×´¶¯Âö²¡±ä¹ØϵµÄÁÙ´²Ñо¿

The Correlation Study between Plasma N-Terminal Pro-B-Type Natriuretic Peptide and Acute Coronary Syndrome;

NT-proBNPÓë¼±ÐÔ¹ÚÂö×ÛºÏÕ÷µÄÏà¹ØÐÔÑо¿

The Role of CD40 Ligand in Acute Coronary Syndrome;

CD40ÅäÌåÔÚ¼±ÐÔ¹ÚÂö×ÛºÏÕ÷ÖеÄÒâÒå

The Relationship between Inflammatory Mediators and Acute Coronary Syndrome;

Ñ×ÐÔ±êÖ¾ÎïºÍ¼±ÐÔ¹ÚÂö×ÛºÏÕ÷µÄ¹Øϵ

Analysis of the Treatment Changes among Acute Coronary Syndrmoe Hospitalized Patients over Past 20 Years;

20Äê¼±ÐÔ¹ÚÂö×ÛºÏÕ÷ÖÎÁƱäǨºÍÏÖ×´

Clinical research of early diagnosis in acute coronary syndrome

ÔçÆÚÕï¶Ï¼±ÐÔ¹ÚÂö×ÛºÏÕ÷µÄÁÙ´²Ñо¿

The Features of Coronary Artery Lesions in Patients with Acute Coronary Syndrome and Glycometabolic Disturbance

ºÏ²¢ÌÇ´úлÒì³£µÄ¼±ÐÔ¹ÚÂö×ÛºÏÕ÷»¼ÕߵĹÚÂö²¡±äÌØÕ÷

Clinical Observation on Treating Acute Coronary Syndrome with Coronary Intervention through Radial Artery

¾­è㶯Âö¼±ÐÔ¹ÚÂö×ÛºÏÕ÷¹Ú×´¶¯Âö½éÈëÖÎÁÆÁÙ´²¹Û²ì

Characteristics of coronary artery lesions in aged patients with acute coronary syndrome and diabetes mellitus and its risk factors

ÀÏÄê¼±ÐÔ¹ÚÂö×ÛºÏÕ÷ºÏ²¢ÌÇÄò²¡»¼ÕߵĹÚÂö²¡±ä¼°ÆäΣÏÕÒòËØ

Analysis of the coronary angiography characteristics in aged patients with acute coronary syndrome and diabetes

ÀÏÄê¼±ÐÔ¹ÚÂö×ÛºÏÕ÷ºÏ²¢ÌÇÄò²¡»¼Õß¹ÚÂöÔìÓ°·ÖÎö

Analysis of Electrocardiogram and Coronary Angiography on Patients with Acute Coronary Syndrome;

¼±ÐÔ¹ÚÂö×ÛºÏÕ÷Ìå±íÐĵçͼÓë¹Ú×´¶¯ÂöÔìÓ°Ïà¹Ø·ÖÎö

Significance and Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome;

¼±ÐÔ¹ÚÂö×ÛºÏÕ÷»¼Õß¹Ú×´¶¯ÂöÖàÑùÓ²»¯COX-2ÓëMMP-9µÄ±í´ï¼°ÒâÒå

The Expression of PAPP-A and COX-2 in Scleratheroma Coronary Artery and Occurrence of ACS;

PAPP-A¡¢COX-2ÔÚÖàÑùÓ²»¯¹ÚÂöµÄ±í´ïÓë¼±ÐÔ¹ÚÂö×ÛºÏÕ÷µÄ·¢Éú

Analysis of Clinical Characteristics and Coronary Angiographic Findings in the Patients with Acute Coronary Syndrome;

¼±ÐÔ¹ÚÂö×ÛºÏÕ÷»¼ÕßÁÙ´²ÌصãÓë¹ÚÂöÔìÓ°½á¹û·ÖÎö

Changes of Serum Concentrations of Matrix Metalloproteinase-9 and Coronary Angiography in Acute Coronary Syndromes;

¼±ÐÔ¹ÚÂö×ÛºÏÕ÷»¼Õß»ùÖʽðÊôµ°°×ø-9Óë¹Ú×´¶¯ÂöÔìÓ°¶ÔÕÕÑо¿

Analysis of Influencing Factors in No-Reflow Phenomenon of Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention

¼±ÐÔ¹ÚÂö×ÛºÏÕ÷»¼Õß¹ÚÂö½éÈëÊõºóÎÞ¸´Á÷ÏÖÏóµÄÓ°ÏìÒòËØ̽ÌÖ

Clinical Study on Acute Coronary Syndrome Patients undergoing Percutaneous Coronary Intervention Treated by Experienced Prescriptions of Deng Tietao

µËÌúÌξ­Ñé·½ÖÎÁƼ±ÐÔ¹ÚÂö×ÛºÏÕ÷¹ÚÂö½éÈëºóµÄÁÙ´²Ñо¿

The Relationship between Serum PAI-1, MMP2 Level and Acute Coronary Syndrome in the Patients with Metabolic Syndrome;

´úл×ÛºÏÕ÷»¼ÕßÖÐѪÇåPAI-1¡¢MMP2ˮƽÓë¼±ÐÔ¹ÚÂö×ÛºÏÕ÷µÄ¹Øϵ